METHOD OF TREATMENT OF INFANTILE HEMANGIOMAS Russian patent published in 2017 - IPC A61K31/165 A61P17/00 A61P35/00 

FIELD: medicine.

SUBSTANCE: for the treatment of infantile hemangiomas with atenolol in children aged 1 month to 3 years old with infantile hemangiomas any form, in the active growth phase, prescribed atenolol at a dose of 0.5 to 1.0 mg/kg body weight of the child per day in 2 receiving the daily dose is divided into equal parts and give every 12 hours. Atenolol administered in two stages, the starting dose of 0.5 mg/kg/day, therapeutic dosage - 1.0 mg/kg/day, treatment of 4 to 6 months. And children from 1 month to 3 months of life, the recommended maximum dose of 0.5 mg/kg body weight, use of the drug on the ECG monitor and holterovsokom monitoring, the drug is prescribed after a cardiac examination, removal of the drug takes place gradually over a period of two weeks, at first, in the first week, atenolol administered at the rate of 50% of the therapeutic dosage in the second week, the drug is prescribed for 25% of the therapeutic dosage. The effectiveness of treatment was assessed a month from the date of the appointment, then every 2 months from the date of initiation of therapy.

EFFECT: blanching of the hemangioma and the reduction of its size.

2 dwg, 2 ex